R
Relmada Therapeutics (RLMD)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Relmada Therapeutics (RLMD)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more
- USD3.83
- USD3.88
- USD3.77
- USD7.22
- -16.10%
- --
- 55.48k
- 113.69k
- 111M
- 2.36
- 19.60%
Stock News
3 hours ago
UPDATE 1-US has been holding up several weapons shipments to Israel for 2 weeks, source says
Yahoo
3 hours ago
Total number of shares and voting rights at April 30, 2024
Yahoo
4 hours ago
10 Best Cookies and Crackers Stocks to Buy
Yahoo
4 hours ago
11 Best Delivery Stocks to Buy According to Hedge Funds
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
